Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer

被引:171
作者
Chandra, A
Guerrero, TM
Liu, HH
Tucker, SL
Liao, ZX
Wang, XC
Murshed, H
Bonnen, MD
Garg, AK
Stevens, CW
Chang, JY
Jeter, MD
Mohan, R
Cox, JD
Komaki, R
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA
关键词
esophageal cancer; intensity-modulated radiotherapy; three-dimensional conformal radiotherapy; treatment planning;
D O I
10.1016/j.radonc.2005.10.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: To evaluate the feasibility whether intensity-modulated radiotherapy (IMRT) can be used to reduce doses to normal lung than three-dimensional conformal radiotherapy (3DCRT) in treating distal esophageal malignancies. Patients and methods: Ten patient cases with cancer of the distal esophagus were selected for a retrospective treatment-planning study. IMRT plans using four, seven, and nine beams (413, 713, and 913) were developed for each patient and compared with the 3DCRT plan used clinically. IMRT and 3DCRT plans were evaluated with respect to PTV coverage and dose-volumes to irradiated normal structures, with statistical comparison made between the two types of plans using the Wilcoxon matched-pair signed-rank test. Results: IMRT plans (413, 713, 9B) reduced total lung volume treated above 10 Gy (V-10), 20 Gy (V-20), mean lung dose (MILD), biological effective volume (V-eff), and lung integral dose (P < 0.05). The median absolute improvement with IMRT over 3DCRT was approximately 10% for V-10, 5% for V-20, and 2.5 Gy for MILD. IMRT improved the PTV heterogeneity (P < 0.05), yet conformity was better with 7B-9B IMRT plans. No clinically meaningful differences were observed with respect to the irradiated volumes of spinal cord, heart, liver, or total body integral doses. Conclusions: Dose-volume of exposed normal lung can be reduced with IMRT, though clinical investigations are warranted to assess IMRT treatment outcome of esophagus cancers. (c) 2005 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 77 (2005) 247-253.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 17 条
  • [1] A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus
    Bedford, JL
    Viviers, L
    Guzel, Z
    Childs, PJ
    Webb, S
    Tait, DM
    [J]. RADIOTHERAPY AND ONCOLOGY, 2000, 57 (02) : 183 - 193
  • [2] Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
    Bosset, JF
    Gignoux, M
    Triboulet, JP
    Tiret, E
    Mantion, G
    Elias, D
    Lozach, P
    Ollier, JC
    Pavy, JJ
    Mercier, M
    Sahmoud, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) : 161 - 167
  • [3] Intensity-modulated radiotherapy: Current status and issues of interest
    Boyer, AL
    Butler, EB
    DiPetrillo, TA
    Engler, MJ
    Fraass, B
    Grant, W
    Ling, CC
    Low, DA
    Mackie, TR
    Mohan, R
    Purdy, JA
    Roach, M
    Rosenman, JG
    Verhey, LJ
    Wong, JW
    Cumberlin, RL
    Stone, H
    Palta, JR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04): : 880 - 914
  • [4] FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION
    BURMAN, C
    KUTCHER, GJ
    EMAMI, B
    GOITEIN, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01): : 123 - 135
  • [5] Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
    Cooper, JS
    Guo, MD
    Herskovic, A
    Macdonald, JS
    Martenson, JA
    Al-Sarraf, M
    Byhardt, R
    Russell, AH
    Beitler, JJ
    Spencer, S
    Asbell, SO
    Graham, MV
    Leichman, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1623 - 1627
  • [6] Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
    Graham, MV
    Purdy, JA
    Emami, B
    Harms, W
    Bosch, W
    Lockett, MA
    Perez, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02): : 323 - 329
  • [7] HISTOGRAM REDUCTION METHOD FOR CALCULATING COMPLICATION PROBABILITIES FOR 3-DIMENSIONAL TREATMENT PLANNING EVALUATIONS
    KUTCHER, GJ
    BURMAN, C
    BREWSTER, L
    GOITEIN, M
    MOHAN, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01): : 137 - 146
  • [8] Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients
    Kwa, SLS
    Lebesque, JV
    Theuws, JCM
    Marks, LB
    Munley, MT
    Bentel, G
    Oetzel, D
    Spahn, U
    Ten Haken, RK
    Drzymala, RE
    Purdy, JA
    Lichter, AS
    Martel, MK
    TEN Haken, RK
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (01): : 1 - 9
  • [9] Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters
    Lee, HK
    Vaporciyan, AA
    Cox, JD
    Tucker, SL
    Putnam, JB
    Ajani, JA
    Liao, ZX
    Swisher, SG
    Roth, JA
    Smythe, WR
    Walsh, GL
    Mohan, R
    Liu, HH
    Mooring, D
    Komaki, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (05): : 1317 - 1322
  • [10] LYMAN JT, 1985, RAD RES S, V8, pS13, DOI DOI 10.2307/3576626